Description

3β-(Methylamino)-4,4,14-Trimethyl-9,19-Cyclo-5α-Pregn-17(20)-En-16-One CAS NO 1053-21-0 is a high-purity, synthetic steroid derivative characterized by its unique 9,19-cycloandrostane structure. This compound is a critical advanced intermediate in the pharmaceutical synthesis of steroidal drugs, offering a versatile scaffold for further chemical modifications. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of novel therapeutic agents, including hormone modulators and anti-inflammatory drugs.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the multi-step synthesis of complex steroidal active pharmaceutical ingredients (APIs).
• Research & Development: Used in medicinal chemistry for the design and synthesis of new steroid-based drug candidates targeting various receptors.
• Hormone Analog Synthesis: A precursor in the production of modified steroid hormones with potential therapeutic applications.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and impurity profiling.
• Biochemical Research: Utilized in studies investigating steroid biosynthesis pathways and enzyme inhibition.

Basic Information

Product Name	3β-(Methylamino)-4,4,14-Trimethyl-9,19-Cyclo-5α-Pregn-17(20)-En-16-One
CAS No.	1053-21-0
Molecular Formula	C₂₅H₃₉NO₂
Molecular Weight	385.59 g/mol
Synonyms	3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one; 3β-Methylamino-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one; 16-Oxo-3β-methylamino-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-ene; 9,19-Cyclopregnane derivative; 3β-Amino-16-keto steroid intermediate; (3β,5α)-3-(Methylamino)-4,4,14-trimethyl-9,19-cyclocholest-17(20)-en-16-one; Pregn-17(20)-en-16-one derivative
EINECS	Contact for details

Quality Control

Our 3β-(Methylamino)-4,4,14-Trimethyl-9,19-Cyclo-5α-Pregn-17(20)-En-16-One is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation by IR and NMR spectroscopy, to ensure it meets the high standards required for pharmaceutical R&D and synthesis. Certificates of Analysis (COA) documenting all critical quality attributes are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.